GR103545
GR103545 is a κ opioid receptor (KOR) selective PET radiotracer and functional agonist with blood-brain barrier permeability and comparable peripheral and central antinociceptive efficacy, with an IC50 of 0.02 nM for KOR agonistic activity. GR103545 selectively binds to KORs in the brain. GR103545 induces antinociceptive effects. GR103545 can be used in research related to neurological disorders such as depression and Alzheimer's disease.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 126766-42-5
- 分子式: C19H25Cl2N3O3
- 分子量:414.33
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Opioid Receptor アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[2]|
κ Opioid Receptor/KOR 0.02 nM (IC50) |
体内実験
GR103545 (compound 2) (in vitro rabbit vas deferens tissue) acts as potent competitive kappa opioid receptor (KOR) agonist with IC50 = 0.02 nM and Log D = 3.14; its s.c./i.c.v. antinociceptive potency ratio is 1.5, showing strong blood-brain barrier penetration[2].
11C-GR103545 (i.v.; bolus injection) exhibits specific, KOR-selective binding in healthy rhesus monkey brain with high BPND values but slow tissue kinetics that delay equilibrium[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 2-4 months of age, ~500 g weight)[1]
-
Dosage:~1 mCi
-
Administration:i.v.; single bolus injection
-
Result:Recorded mean baseline BPND values across KOR-abundant brain nuclei ranging 0.55-0.66.
Found average SUV reductions of 60%, 86% and 77% in KOR-rich brain areas after i.v. pre-treatment with racemic GR103545, naloxone and LY2795050 separately.
Identified dose-dependent BPND suppression by i.v. salvinorin A with a KOR occupancy EC50 of 0.36 mg/kg.
Documented time-variant baseline BPND suppression ratios of 55%, 51%, 60% and 88% at 1 min, 1 h, 2.5 h and 5 h post 0.60 mg/kg i.v. salvinorin A injection.
化学情報
-
CAS 番号 126766-42-5
-
分子量 414.33
-
分子式 C19H25Cl2N3O3
-
SMILES
ClC(C=C1CC(N2[C@@H](CN(CC2)C(OC)=O)CN3CCCC3)=O)=C(C=C1)Cl
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
純度とドキュメンテーション
参考文献
[1]. Placzek MS, et al. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2015 Dec;40(13):2865-72. [Content Brief]
[3]. Li S, et al. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2019 Jul;60(7):1023-1030. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)